| | AXDND1, NPHS2 (V290M +1 more) | Single nucleotide variant (missense variant +1 more) | NPHS2-related disorder +2 more | GPathogenic/Likely pathogenic |
| | AXDND1, NPHS2 (R286fs +1 more) | Deletion (frameshift variant +1 more) | Focal segmental glomerulosclerosis +3 more | GPathogenic/Likely pathogenic |
| | AXDND1, NPHS2 (R201S +1 more) | Single nucleotide variant (missense variant +1 more) | Nephrotic syndrome, type 2 | |
| | AXDND1, NPHS2 (E264Q +1 more) | Single nucleotide variant (missense variant +1 more) | Nephrotic syndrome, type 2 +2 more | GConflicting classifications of pathogenicity |
| | AXDND1, NPHS2 (V260E +1 more) | Single nucleotide variant (missense variant +1 more) | Nephrotic syndrome, type 2 +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Focal segmental glomerulosclerosis +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | not provided +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | not provided +1 more | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | GPathogenic/Likely pathogenic |
| | | Duplication (frameshift variant) | Nephrotic syndrome, type 2 +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Chronic kidney disease +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |